DoW Kidney Cancer, Idea Development Award

The Kidney Cancer Research Program Idea Development Award is offered by the Defense Health Agency through the Congressionally Directed Medical Research Programs to support innovative and high-impact research addressing kidney cancer. The program was established as part of a broader congressional effort to accelerate medical research benefiting service members, veterans, and the general public. Since its inception in 2017, the program has funded numerous projects focused on advancing scientific understanding and improving patient outcomes. The initiative reflects a continued federal commitment to addressing critical gaps in kidney cancer research through targeted funding opportunities. The primary purpose of this award is to foster the development of novel, hypothesis-driven research ideas that have the potential to significantly advance the field of kidney cancer. Applicants are expected to propose projects grounded in strong scientific rationale, supported by preliminary data, and designed with a clear and feasible research approach. The program emphasizes innovation and encourages projects that challenge existing paradigms or explore new directions in kidney cancer biology, diagnosis, treatment, and patient care. Research must align with at least one of the program’s defined focus areas, which include understanding disease mechanisms, improving early detection, developing therapies, and enhancing quality of life for patients. Funding is structured to support either a single principal investigator or a collaborative partnership between two investigators. The maximum total funding is capped at 900000 dollars for single investigator projects and 1200000 dollars for partnered projects, with a performance period of up to three years. Funds may be used for research-related expenses including personnel, supplies, and limited travel for collaboration and dissemination of findings. However, clinical trials are explicitly not permitted under this funding opportunity, and certain restrictions apply to ensure ethical compliance and alignment with federal research standards. Eligibility for this program is broad and inclusive, allowing applications from domestic and international organizations, including academic institutions, nonprofit organizations, for-profit entities, and government agencies. Principal investigators must be at or above the level of Assistant Professor or equivalent and may only submit one application to this funding opportunity. Awards are granted to organizations rather than individuals, and cost sharing is not required, lowering barriers to participation and encouraging a wide range of applicants. The application process follows a two-step submission structure. Applicants must first submit a pre-application in the form of a letter of intent through the eBRAP system. Following this, a full application must be submitted either through Grants.gov or eBRAP depending on the applicant’s organizational type. The full application requires multiple components including a detailed project narrative, technical and lay abstracts, supporting documentation, and a statement of work. Applications are evaluated through a two-tier review process consisting of peer review and programmatic review, focusing on scientific merit, feasibility, impact, and alignment with program priorities. Key deadlines for the current cycle include a pre-application submission deadline of September 14, 2026 and a full application deadline of September 28, 2026. Peer review is anticipated in December 2026, followed by programmatic review in March 2027. Funding decisions are expected thereafter, with awards issued no later than September 30, 2027. The program is part of an annual funding cycle, suggesting recurring opportunities for applicants in future years. Applicants are encouraged to begin preparations early due to registration requirements and the complexity of the submission process.

Strong preliminary data and a clearly articulated hypothesis are critical; align proposal with focus areas and demonstrate high impact potential; ensure feasibility and statistical rigor